These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

114 related items for PubMed ID: 8121078

  • 1. Effects of KW-3635, a specific thromboxane A2-receptor antagonist, on the development of lupus nephritis in NZB x NZW F1 mice.
    Kawakage M, Mizumoto H, Nukui E, Sato S, Karasawa A.
    Jpn J Pharmacol; 1993 Dec; 63(4):433-8. PubMed ID: 8121078
    [Abstract] [Full Text] [Related]

  • 2. Protective effect of KW-3635, a specific thromboxane A2-receptor antagonist, on experimental glomerulonephritis in mice.
    Kawakage M, Sato K, Karasawa A.
    Jpn J Pharmacol; 1994 Jun; 65(2):163-6. PubMed ID: 7967228
    [Abstract] [Full Text] [Related]

  • 3. Thromboxane receptor blockade reduces renal injury in murine lupus nephritis.
    Spurney RF, Fan PY, Ruiz P, Sanfilippo F, Pisetsky DS, Coffman TM.
    Kidney Int; 1992 Apr; 41(4):973-82. PubMed ID: 1387435
    [Abstract] [Full Text] [Related]

  • 4. Antithrombotic effects of KW-3635, a thromboxane A2-receptor antagonist, in guinea pigs.
    Shirakura S, Higo K, Takeda M, Karasawa A.
    Jpn J Pharmacol; 1994 Jun; 65(2):93-8. PubMed ID: 7967232
    [Abstract] [Full Text] [Related]

  • 5. [Effects of KW-3635 on the diuretic action of furosemide in rats].
    Kawakage M, Ishihara N, Karasawa A, Kase H.
    Nihon Yakurigaku Zasshi; 1993 Jan; 101(1):33-8. PubMed ID: 8444379
    [Abstract] [Full Text] [Related]

  • 6. Inhibitory effect of KW-3635, a new thromboxane A2-receptor antagonist, on arterial thrombosis in guinea pigs.
    Higo K, Karasawa A.
    Jpn J Pharmacol; 1993 Dec; 63(4):521-3. PubMed ID: 8121085
    [Abstract] [Full Text] [Related]

  • 7. Antiplatelet effects of the novel thromboxane A2 receptor antagonist sodium (E)-11-[2-(5,6-dimethyl-1-benzimidazolyl)-ethylidene]-6,11- dihydrodibenz[b,e] oxepine-2-carboxylate monohydrate.
    Karasawa A, Kawakage M, Shirakura S, Higo K, Kubo K, Ohshima E, Obase H.
    Arzneimittelforschung; 1991 Dec; 41(12):1230-6. PubMed ID: 1840011
    [Abstract] [Full Text] [Related]

  • 8. Effective therapy for nephritis in (NZB x NZW)F1 mice with triptolide and tripdiolide, the principal active components of the Chinese herbal remedy Tripterygium wilfordii Hook F.
    Tao X, Fan F, Hoffmann V, Gao CY, Longo NS, Zerfas P, Lipsky PE.
    Arthritis Rheum; 2008 Jun; 58(6):1774-83. PubMed ID: 18512813
    [Abstract] [Full Text] [Related]

  • 9. Effect of a specific endothelin A receptor antagonist on murine lupus nephritis.
    Nakamura T, Ebihara I, Tomino Y, Koide H.
    Kidney Int; 1995 Feb; 47(2):481-9. PubMed ID: 7723234
    [Abstract] [Full Text] [Related]

  • 10. Mycophenolate mofetil combined with a cyclooxygenase-2 inhibitor ameliorates murine lupus nephritis.
    Zoja C, Benigni A, Noris M, Corna D, Casiraghi F, Pagnoncelli M, Rottoli D, Abbate M, Remuzzi G.
    Kidney Int; 2001 Aug; 60(2):653-63. PubMed ID: 11473648
    [Abstract] [Full Text] [Related]

  • 11. Improvement of renal function with selective thromboxane antagonism in lupus nephritis.
    Pierucci A, Simonetti BM, Pecci G, Mavrikakis G, Feriozzi S, Cinotti GA, Patrignani P, Ciabattoni G, Patrono C.
    N Engl J Med; 1989 Feb 16; 320(7):421-5. PubMed ID: 2643773
    [Abstract] [Full Text] [Related]

  • 12. Improvement of renal function with a selective thromboxane A2 synthetase inhibitor, DP-1904, in lupus nephritis.
    Yoshida T, Kameda H, Ichikawa Y, Tojo T, Homma M.
    J Rheumatol; 1996 Oct 16; 23(10):1719-24. PubMed ID: 8895147
    [Abstract] [Full Text] [Related]

  • 13. Long-term thromboxane-synthase inhibition prolongs survival in murine lupus nephritis.
    Salvati P, Lamberti E, Ferrario R, Ferrario RG, Scampini G, Pugliese F, Barsotti P, Patrono C.
    Kidney Int; 1995 Apr 16; 47(4):1168-75. PubMed ID: 7783415
    [Abstract] [Full Text] [Related]

  • 14. Antiproteinuric effect of a thromboxane receptor antagonist, S-1452, on rat diabetic nephropathy and murine lupus nephritis.
    Matsuo Y, Takagawa I, Koshida H, Kawabata T, Nakamura M, Ida T, Zhou L, Marumo F.
    Pharmacology; 1995 Jan 16; 50(1):1-8. PubMed ID: 7899476
    [Abstract] [Full Text] [Related]

  • 15. Suppression of renal disease and mortality in the female NZB x NZW F1 mouse model of systemic lupus erythematosus (SLE) by chenodeoxycholic acid.
    Suwannaroj S, Lagoo A, McMurray RW.
    Lupus; 2001 Jan 16; 10(8):562-7. PubMed ID: 11530998
    [Abstract] [Full Text] [Related]

  • 16. The Ox40/Ox40 Ligand Pathway Promotes Pathogenic Th Cell Responses, Plasmablast Accumulation, and Lupus Nephritis in NZB/W F1 Mice.
    Sitrin J, Suto E, Wuster A, Eastham-Anderson J, Kim JM, Austin CD, Lee WP, Behrens TW.
    J Immunol; 2017 Aug 15; 199(4):1238-1249. PubMed ID: 28696253
    [Abstract] [Full Text] [Related]

  • 17. Actions of the novel thromboxane A2 receptor antagonist sodium (E)-11-[2-(5,6-dimethyl-1-benzimidazolyl)-ethylidene]-6,11- dihydrodibenz[b,e]oxepine-1-carboxylate monohydrate on smooth muscle preparations.
    Karasawa A, Shirakura S, Higo K, Kubo K.
    Arzneimittelforschung; 1991 Dec 15; 41(12):1237-41. PubMed ID: 1815522
    [Abstract] [Full Text] [Related]

  • 18. Effects of KW-3635, a novel dibenzoxepin derivative of a selective thromboxane A2 antagonist, on human, guinea pig and rat platelets.
    Miki I, Kishibayashi N, Nonaka H, Ohshima E, Takami H, Obase H, Ishii A.
    Jpn J Pharmacol; 1992 Jul 15; 59(3):357-64. PubMed ID: 1434130
    [Abstract] [Full Text] [Related]

  • 19. Differences in expression of lupus nephritis in New Zealand mixed H-2z homozygous inbred strains of mice derived from New Zealand black and New Zealand white mice. Origins and initial characterization.
    Rudofsky UH, Evans BD, Balaban SL, Mottironi VD, Gabrielsen AE.
    Lab Invest; 1993 Apr 15; 68(4):419-26. PubMed ID: 8479150
    [Abstract] [Full Text] [Related]

  • 20. Beneficial effect of the novel thromboxane A2 receptor antagonist sodium (E)-11-[2-(5,6-dimethyl-1-benzimidazolyl)ethylidene]-6,11- dihydrodibenz[b,e]oxepine-2-carboxylate monohydrate on collagen-induced coronary ischemia in guinea-pigs.
    Kawakage M, Shirakura S, Karasawa A, Takeda M, Miki I, Ishii A, Kubo K.
    Arzneimittelforschung; 1991 Dec 15; 41(12):1246-50. PubMed ID: 1815524
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.